Delivery Order SPE2DX22D0010-SPE2D825FEB42

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $4.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,160.81, is for the delivery of Fentanyl Transdermal Patches at 37.5 mcg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 2, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,892.28, is for the delivery of Fentanyl Transderm Patches at 37.5 mcg. The contract has an ultimate completion date of November 1, 2023 and is a Firm Fixed Price Delivery Order. There was no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a $12,483.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567480596 - Fentanyl Transdermal Patches, 37.5 mcg, with a period of performance through March 7, 2025. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl Transderm Patches, a specialized pharmaceutical product. The contract has a total ceiling value of $4,551.74 and an ultimate completion date of February 20, 2025. This delivery order contract is associated with a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl Transderm Patches, a medical product used for pain management. The contract has a ceiling value of $2,488.32 and a period of performance running through February 13, 2025. The contract has a firm fixed price pricing type and is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $7,044.15, is for the delivery of Fentanyl Transdermal Patches with a 37.5 mcg dosage. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,283.16 firm fixed-price contract is for the provision of FENTANYL TRANSDERM PATCH 37.5MCG, a critical pain management medication. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FTR17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Fentanyl Transderm Patch 37.5mcg, a pharmaceutical product, with a ceiling value of $2,120.92 and a completion date of September 28, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
This federal contract award, SPE2DX22D0010|SPE2D825FBW72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl Transderm Patch 37.5MCG, a pain management medication, with a ceiling value of $3,681.08. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 13, 2024. This award is not designated...
This federal contract award, valued at $5,842.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FEB42
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl Transderm Patches at 37.5 mcg, with a ceiling value of $4,215.70 and a performance period ending on March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:55 AM